CCP
ACAD icon

Corient Capital Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Corient Capital Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,542
Closed -$207K – 689
2022
Q1 		$207K Buy
+8,542
New +$207K 0.01% 675